Patent details

EP3448378 Title: PLA2 AND HMG-COA INHIBITORS FOR TREATMENT OF PATHOLOGICAL CONDITIONS CAUSING HEMOLYSIS, CEREBRAL EDEMA, AND ACUTE KIDNEY INJURY

Basic Information

Publication number:
EP3448378
PCT Application Number:
US2017030436
Type:
European Patent Granted for LU
Legal Status:
Unitary Effect Registered
Application number:
EP177906435
PCT Publication Number:
WO2017190141
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PLA2 AND HMG-COA INHIBITORS FOR TREATMENT OF PATHOLOGICAL CONDITIONS CAUSING HEMOLYSIS, CEREBRAL EDEMA, AND ACUTE KIDNEY INJURY
French Title of Invention:
INHIBITEURS DE PLA2 ET HMG-COA POUR LE TRAITEMENT DES AFFECTIONS PATHOLOGIQUES PROVOQUANT UNE HÉMOLYSE, UN OEDÈME CÉRÉBRAL, ET UNE INSUFFISANCE RÉNALE AIGUË
German Title of Invention:
PLA2 UND HMG-COA-INHIBITOREN ZUR BEHANDLUNG VON PATHOLOGISCHEN ZUSTÄNDEN, DIE HÄMOLYSE, ZEREBRALES ÖDEM UND AKUTE NIERENSCHÄDIGUNG VERURSACHEN
SPC Number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
13/05/2024
Link to UPP Register:
European Patent Register
Unitary Effect Request Withdrawal Date:
Unitary Effect Status:
Unitary Effect Registered
Unitary Effect Acceptance Decision Date:
23/05/2024
Unitary Effect Rejection Decision Date:
Unitary Effect Date:
17/04/2024
Unitary Effect Registration Date:
23/05/2024
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Explanatory Text UE:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC Number:

Dates

Filing date:
01/05/2017
Grant date:
17/04/2024
EP Publication Date:
06/03/2019
PCT Publication Date:
02/11/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/04/2024
EP B1 Publication Date:
17/04/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
01/05/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/04/2024
 
 

Name:
Ophirex, Inc.
Address:
5643 Paradise Drive No. 2, Corte Madera, CA 94925, United States (US)

Inventor

Name:
LEWIN, Matthew R.
Address:
United States (US)

Priority

1

Priority Number:
201662329611 P
Priority Date:
29/04/2016
Priority Country:
United States (US)

2

Priority Number:
201662340075 P
Priority Date:
23/05/2016
Priority Country:
United States (US)

3

Priority Number:
201662423693 P
Priority Date:
17/11/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/404; A61K 31/16; A61K 31/19; A61P 39/02; A61K 31/192; A61K 31/22; A61K 31/366; A61K 31/40; A61K 31/437; A61K 45/06;

Publication

European Patent Bulletin

1

Issue number:
202416
Publication date:
17/04/2024
Description:
Grant (B1)

2

Issue number:
202425
Publication date:
19/06/2024
Description:
Unitary Effect Request Receipt

3

Issue number:
202426
Publication date:
26/06/2024
Description:
Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages